The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
VELCADE (Bortezomib) receives European marketing authorisation

ghted that marketing authorisation for VELCADE has been granted, as it is the first major advance for patients with multiple myeloma in more than a decade, and marks the company's commitment to Oncology." said Ken Watters, European Medical Director, Ortho Biotech.

"The approval of VELCADE today brings renewed hope to thousands of European multiple myeloma patients and their families" said Eric Low, Executive Director, International Myeloma Foundation (UK). "The multiple myeloma advocacy community has campaigned tirelessly over the years for cutting edge treatments such as VELCADE to be made available to patients, this is a very proud day", he continued.

The findings of a pre-specified interim analysis from an ongoing phase III trial which compared VELCADE to dexamethasone in refractory multiple myeloma patients found a statistically significant improvement in time to disease progression the primary endpoint of the trial in patients receiving VELCADE compared to patients receiving high-dose dexamethasone. Patients in the control arm of the trial were given the opportunity to switch to VELCADE as soon as possible based on an interim analysis that found a statistically significant improvement in TTP in patients receiving VELCADE compared to patients receiving dexamethasone.

VELCADE has a generally predictable, manageable safety profile (with appropriate monitoring and if necessary, dose modification). VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron, or mannitol. There are approximately 50 ongoing clinical trials (in Europe and the US) investigating the potential of VELCADE in all stages of multiple myeloma and other cancers.

A single licence has been granted to market VELCADE in the 15 member states of the EU, plus Norway and Iceland. In addition it will be available in the 10 accession countries.

VELCADE is being co-developed by Millennium Pharmaceuticals, Inc. and Johnson & Johnson Ph
'"/>

Contact: Eva Reynolds
eva_reynolds@uk.bm.com
44-20-7831-6262
Burson-Marsteller
28-Apr-2004


Page: 1 2 3

Related medicine news :

1. VELCADE(TM) data confirms long-term survival
2. UIC professor receives international humanitarian award
3. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
4. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
5. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
6. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
7. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
8. American Academy of Neurology program receives Grassroots Award
9. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
10. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
11. Pfizers antifungal medicine VFEND receives FDA approval
Post Your Comments:
(Date:11/21/2008)...d to new therapies for preterm labor , ,...ay they,ve found the switch that activates the ute...finding that may lead to therapies for preterm lab... the protein IP on the surface of these uterine mu...g pregnancy. , But researchers from Dartmouth ...
(Date:11/21/2008)...1, 2008)The University of Texas Health Science Cen... Excellence in Aging Studies (TEXAS), to promote g...gious $2 million award from the Donald W. Reynolds... "This will allow us to teach geriatric medicine p... student to practicing physicians. With the reach ...
(Date:11/21/2008)... Nov. 21 The Generic,P...owing statement today from,GPhA President and CEO...ssion,(FTC) roundtable on "Emerging Health Care C...e fact that the FTC is conducting this roundtable ... that consumers have access to safe and,affordabl...
(Date:11/21/2008)...1 The University of Te...ning of a collaborative effort to eradicate breast...st Cancer Awareness and Research of the Americas t...f the United States, and Vivian Fernandez de Torri...M. D. Anderson in the initiative are the U.S. Depa...
Breaking Medicine News(10 mins):Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3
Other News:
... and melting snow caused Germany's Elbe River to r...e country over the weekend, flooding cities and da...e has been monitoring the situation from space.......r Saxony about 100 kilometres from the Baltic Sea,...
...arm and attempted suicide are high within Goth you...today.......Deliberate self harm is common among y...particularly widespread in certain populations and...nd various psychiatric disorders in later life. Co...
... will be saved if condom use is heavily promoted a...e US President's Emergency Plan for AIDS Relief (P...f The Lancet.......In January 2003, President Geor...S$15 billion in funding between 2004 and 2008, to ...
Johns Hopkins Medicine...Media Relations and Public Affairs...Media Contact: Audrey Huang...410-614-5105; audrey@jhmi.edu ...April 13, 2006......Published in the March 17 issue of Science, their lizar
health news:Massive German floods monitored from space 2health news:Self harm high among Goth youths 2health news:Condom use needs to be heavily promoted if Bush's emergency plan for AIDS relief is to work 2health news:Lizard 'third eye' sheds light on evolution of color vision 2
...en's Hospital Medical Center have identified a mis... in cystic fibrosis (CF). ......CF is a life-thre...infections and impairs digestion. The discovery, ...y, provides impetus for the development of novel t...
...vances in breast cancer therapies. Still, the dise...ntists have yet to develop a living model with whi...tumor behavior. ......Now, a team in the lab of sc... Biomedical Research has successfully grafted huma...
....M. U.S. EST) Scientists from the New York-based ...aborators from the US Geological Survey's wildlife...l that shows a solid quantitative relationship bet...e to these highly endangered big cats. Published ...
...avior have paid off for Ohio State University prof...f the prestigious 2004 Stockholm Water Prize. .......r Prize is equivalent to winning a Nobel Prize, sa...ources and environmental science at Ohio State Uni...
Study reveals important new factor in cystic fibrosis lung inflammation 2Study reveals important new factor in cystic fibrosis lung inflammation 3Study offers new model for breast cancer 2Tigers: Big cats need cat food 2Ohio State wetlands professor wins prestigious Water Prize 2
... the most widespread and devastating gastrointesti...nquered simply by adding a common polypeptide, epi... if so, exactly how does it work, and why?......Ne...infants annually in the U.S., and over 90% are fo...
...ring agents, such as the widely-prescribed statin ...o be "novel therapeutic agents to modify cellular ...monary hypertension," according Hemal H. Patel who...he University of California, San Diego (UCSD)........
...otal evidence suggested that ovulating or pregnant...pplements, experienced fewer asthma attacks and le...t perhaps estrogen affects airway smooth muscle fu...cteristic of asthma and other chronic lung disease...
Blue-green algae, or cyanobacteria, in the seas are as vital to the survival of life on earth as the oxygen producing plants are on land. But marine bacteria are attacked by viruses, which can serious
Growth factor in baby formula could reduce NEC, most devastating GI disease in preemies 2Growth factor in baby formula could reduce NEC, most devastating GI disease in preemies 3Statins, other cholesterol depletors, may disrupt hypertension development: UCSD study 2Statins, other cholesterol depletors, may disrupt hypertension development: UCSD study 3Estrogen, SERMS reduce asthma impact by halting constriction 2Estrogen, SERMS reduce asthma impact by halting constriction 3Scientists find viruses can't stick to sea bugs in the dark 2